BASP-1 was identified as being upregulated in SCLC compared with LCNEC by Nomura et al. and Fukuda et al. The same two studies also identified AL1A1 and ENOB as downregulated in SCLC compared with LCNEC [33,35]. The gene discussed is BASP1; the disease is large cell neuroendocrine carcinoma.